Essentials of Inorganic Chemistry for Pharmacy and Medicinal Chemistry Students

Introduction to Medicinal Inorganic Chemistry

• Definition: Medicinal inorganic chemistry is the area of research concerned with metal ions and metal complexes and their clinical applications. It involves the development of metal-based therapeutic agents, the interaction of metals and proteins, metal chelation, and the general functions of metals in living systems.
• Historical Context: The therapeutic value of metal ions has been known for thousands of years. Arsenic was used in clinical studies over 100 years ago, while silver, gold, and iron have been used in therapeutic applications for more than 5,000 years.
• Modern Applications:
  • Anticancer Agents: Transition metals like Platinum (Cisplatin).
  • Diagnostic Agents: Gadolinium for MRI or Technetium for imaging.
  • Treatment of High Phosphate Levels: Lanthanum salts.
  • Rheumatoid Arthritis: Gold compounds.
• Unique Properties of Metal Complexes:
  • Coordination and Redox Behavior: Metals can participate in electron transfer reactions (PDT - Photodynamic Therapy).
  • Magnetic Moments: Used in imaging reagents for Magnetic Resonance Imaging (MRI).
  • Radioactivity: Radioactive isotopes serve as radiopharmaceuticals for therapy and imaging.
  • Aqueous Solubility: High aqueous solubility of cations allows unique interactions with biomolecules.
• The Bertrand Diagram: Visualizes the relationship between physiological response and metal concentration. Essential metals have an optimum concentration range; concentrations above this are toxic (detrimental/death), and below are deficient (detrimental/death).

Basic Inorganic Principles: Atomic Structure

• Definition of an Atom: The smallest unit that retains the properties of an element. Dalton’s Atomic Theory states all matter is composed of atoms; they cannot be made or destroyed. A modern definition states atoms are units that cannot be created, destroyed, or transformed into other atoms in a chemical reaction.
• Subatomic Particles:
  • Protons: Positively charged; mass ≈ $1.6726 \times 10^{-24}\,g$.
  • Neutrons: No charge; mass ≈ $1.6749 \times 10^{-24}\,g$.
  • Electrons: Negatively charged; mass ≈ $9.1094 \times 10^{-28}\,g$ (negligible).
• Atomic Notations:
  • Z (Atomic Number): Number of protons (and electrons in a neutral atom).
  • A (Mass Number): Total number of protons plus neutrons.
  • Isotopes: Versions of an element with the same $Z$ but different number of neutrons (e.g., Hydrogen has Protium ($0$ neutrons), Deuterium ($1$ neutron), and Tritium ($2$ neutrons)).
• Atomic Models:
  • Bohr Model (1913): Electrons circle the nucleus on fixed orbits (quantization of energy). Distance from the nucleus is proportional to energy level ($n$).
  • Wave Mechanics (1924-1926): Louis de Broglie proposed wave-particle duality. Schrödinger published the wave equation describing electrons as wave functions (atomic orbitals).
  • Heisenberg’s Uncertainty Principle: It is impossible to determine the exact momentum and position of an electron simultaneously.

Electronic Structure and Quantum Numbers

• Principal Quantum Number ($n$): Represents energy levels ($1 \le n \le \infty$).
• Orbital Quantum Number ($l$): Represents the shape of the orbital ($l = 0, 1, 2, \dots, (n-1)$). Labels are $s$, $p$, $d$, and $f$.
• Magnetic Quantum Number ($m_l$): Orientation in space ($+l$ to $-l$).
  • $s$-orbital ($l=0$): 1 orientation ($m_l=0$).
  • $p$-orbital ($l=1$): 3 orientations ($p_x, p_y, p_z$).
  • $d$-orbital ($l=2$): 5 orientations.
• Spin Quantum Number ($s$): Value of $+1/2$ or $-1/2$.
• Rules for Configuration:
  • Pauli Exclusion Principle: No two electrons in the same atom can have the same four quantum numbers.
  • Aufbau Principle: Fill lowest energy levels first ($1s$ before $2s$).
  • Hund’s Rule: Fill orbitals of the same energy level with one electron first before pairing.
  • Madelung Energy Ordering Rule: Determines the order of orbital occupation.
• Valence Electrons: Electrons in the outermost shell that participate in chemical bonding.

Chemical Bonds and Intermolecular Forces

• Lewis Structures: Dots visualize valence electrons. Pairs contribute to bonds or exist as lone pairs.
• Octet Rule: Atoms (Z < 20) tend to form molecules so they have eight electrons in their valence shell (noble gas configuration).
• VSEPR (Valence Shell Electron Pair Repulsion): Predicts molecular shape based on electron pairs repelling each other to be furthest apart.
• Covalent Bond: Based on the sharing of electron pairs.
  • Valence Bond (VB) Theory: Overlap of half-filled valence atomic orbitals.
  • Molecular Orbital (MO) Theory: Combination of atomic orbitals to form bonding and nonbonding MOs covering the whole molecule.
  • Electronegativity (EN): Tendency to attract electrons. Trends: Increase across a period, decrease down a group.
• Ionic Bond: Strong electrostatic attraction between a cation (+) and an anion (–) following electron transfer. Forms salts with high melting points.
• Metallic Bond: Metal atoms donate valence electrons to a delocalized pool surrounding a network of atoms.
• Intermolecular Forces:
  • van der Waals: Weakest; temporary dipoles caused by moving electrons.
  • Dipole-Dipole: Electrostatic interaction between permanent dipoles in heteronuclear molecules.
  • Hydrogen Bonding: Strongest intermolecular force; occurs between H and highly electronegative atoms (F, O, N).

Alkali Metals (Group 1)

• Elements: Li, Na, K, Rb, Cs, Fr. (Hydrogen is excluded).
• General Chemistry: s-block metals with one valence electron ($ns^1$). Characterized by the formation of $M^+$ ions due to low ionization energy.
• Extraction:
  • Sodium: Manufactured via the Downs’ process (electrolysis of molten NaCl). $CaCl_2$ is added to lower the melting point from $800\,^{\circ}C$ to $600\,^{\circ}C$.
    • Reduction (Cathode): $Na^+(l) + e^- \rightarrow Na(l)$.
    • Oxidation (Anode): $2Cl^-(l) \rightarrow Cl_2(g) + 2e^-$.
• Redox Reactions: Chemical reactions involving changes in oxidation number.
  • Oxidation: Loss of electrons (increase in oxidation state).
  • Reduction: Gain of electrons (decrease in oxidation state).
  • Oxidation State Rules: Free elements are $0$; monatomic ions equal their charge; H is typically $+1$, O is $-2$; sum in a neutral molecule is $0$.
• Standard Reduction Potential ($E^0$): Measures the tendency of a species to be reduced. The half-equation with the more positive value is the reduction.
  • $E^0_{\text{cell}} = E^0_{\text{red}} + E^0_{\text{ox}}$.

Lithium Therapy and Biological Importance

• Medical Use: Treatment of Bipolar Disorder (BD) and mania. Primarily administered as Lithium Carbonate ($Li_2CO_3$) or Lithium Citrate.
• Bio-Isotopes: $^6\text{Li}$ ($7.59\%$) and $^7\text{Li}$ (92.41\%\). NMR technology can monitor uptake by differentiating between intracellular and extracellular concentrations.\n* **Mechanism of Action**: Largely unknown, but involves the displacement of Mg^{2+}$by$Li^+ due to **Diagonal Relationship** (similar ionic radii and solubility).\n * **GSK-3 Inhibition**: Inhibits Glycogen Synthase Kinase-3 by competing for Mg^{2+} binding, potentially protecting against disease-induced cell death.\n * **PME Inhibition**: Inhibits Inositol Monophosphatase (InsP), perturbing transcellular communication.\n* **Pharmacokinetics**: Administered orally (~30\,\text{mmol/day}). Distributed uniformly, except for higher concentrations in bones and endocrine glands.\n* **Monitoring**: Extremely narrow therapeutic index (0.4\text{--}1.0\,\text{mmol/l}$). Concentrations >$1.5\,\text{mmol/l}$cause toxicity (tremors, renal impairment); >$2.0\,\text{mmol/l} is fatal.\n* **Interactions**: NSAIDs can increase Li levels by 60\%) by reducing renal clearance.

Sodium and Potassium: Electrolytes and Transport

• Sodium (Na): Principal cation in extracellular fluid (90\%\). Maintains body fluids via **Osmosis**.\n * **Osmosis**: Diffusion of solvent (water) across semi-permeable membranes towards high salt concentrations.\n * **Clinical use**: NaCl solutions for depletion/dehydration. Sodium Bicarbonate for regulating serum pH in renal tubular acidosis.\n * **Hyponatraemia**: Low sodium; causes low blood pressure and muscle cramps.\n * **Hypernatraemia**: High sodium; linked to hypertension and cardiovascular disorders.\n* **Potassium (K)**: Essential intracellular cation (95\%). Vital for neurons and muscle cells.
  • Action Potential: Short-lived change in membrane potential. Steps: Threshold reaches → $Na^+$ channels open → membrane depolarizes → $K^+$ channels open → $K^+$ leaves cell → membrane repolarizes (hyperpolarization).
  • Nernst Equation: Calculations of electric potential for an ion:
    • $\Delta E = \frac{-0.059}{z}\,V \times \log\left(\frac{[ion]_{\text{in}}}{[ion]_{\text{out}}}\right)$.
• Hypokalaemia: Low plasma K ($< 3.5\,\text{mmol/l}$). Treated with liquid KCl or oral supplements (< $100\,\text{mg}$/pill to prevent gastric injury).
• Hyperkalaemia: High plasma K ($> 5.0\,\text{mmol/l}$). > $6.5\,\text{mmol/l}$ risk of cardiac arrest. Emergency treatment: IV Calcium Gluconate (protects heart), insulin (shifts K into cells), or exchange resins.
• Na/K-ATPase Pump: Active transport using ATP. Expels 3 $Na^+$ and imports 2 $K^+$ against concentration gradients.

Alkaline Earth Metals (Group 2)

• Elements: Be, Mg, Ca, Sr, Ba, Ra. Divalent cations ($M^{2+}$) with noble gas configuration.
• Beryllium (Be): Highly toxic; causes Chronic Beryllium Disease (CBD) (lung scarring). Used in high-speed aircraft.
• Magnesium (Mg): Eighth most abundant element. Essential for manipulated ATP, DNA, and RNA structures.
  • Milk of Magnesia: $Mg(OH)_2$ suspension used as an antacid and laxative.
  • Magnesium Trisilicate ($Mg_2Si_3O_8$): Antacid used for peptic ulcers.
  • Clinical Use: IV/IM $MgSO_4$ for severe arrhythmias and eclampsia in pregnancy.
• Calcium (Ca): Most abundant inorganic element in humans. stored in bones (99\%\) as **Hydroxylapatite (Ca_{10}(PO_4)6(OH)_2)**.\n * **Homeostasis**: Regulated by Calciotropic hormones (Parathyroid Hormone - PTH) which release Ca from bones when plasma levels are low.\n * **Deficiency**: Linked to Osteoporosis, hypertension, and colon cancer. Recommended daily intake varies (400\,\text{mg}$for neonates to$1500\,\text{mg} for postmenopausal women/elderly).\n * **Renal Osteodystrophy**: Bone mineralization deficiency in renal failure due to failure to activate Vitamin D into Calcitriol.\n * **Calcium Supplements**: Carbonate (40\%\,Ca^{2+}$), Citrate ($24\%\,Ca^{2+}$), Lactate ($18\%\,Ca^{2+}$), Gluconate ($9\%\,Ca^{2+}).\n* **Barium (Ba)**: **Barium Meal** (BaSO_4$suspension) is an oral radio-contrast agent for X-ray imaging of the digestive tract. Toxic salts like$BaCO_3 are used as rat poison.\n\n# The Boron Group (Group 13)\n\n* **Elements**: B, Al, Ga, In, Tl. Stable cation M^{3+}.\n* **Boron (B)**: Metalloid. Boric Acid (B(OH)_3) used as antifungal and eyewash.\n * **Bortezomib (Velcade)**: Proteasome inhibitor for multiple myeloma. Boron binds to the catalytic site of 26S proteasome.\n* **Aluminium (Al)**: Most abundant metal in earth’s crust. No known biological role.\n * **Adjuvants**: Potassium alum or Al(OH)_3 added to vaccines (diphtheria, hepatitis) to increase antibody response via a slow-release depot.\n * **Antacids**: Al(OH)_3$neutralizes stomach acid ($HCl$) to form$AlCl_3 and water. Often combined with Mg to prevent constipation.\n * **Phosphate Binders**: Given in renal failure to bind phosphate in the intestines; excreted in faeces.\n * **Toxicity**: Cumulative exposure can cause Dialysis Dementia or osteomalacia.\n* **Gallium (Ga)**: Ga^{3+}$mimics$Fe^{3+}$but cannot be reduced to$+2 state.\n * **Gallium Nitrate (Ganite)**: FDA-approved for cancer-associated hypercalcaemia. Inhibits bone turnover.\n * **Anticancer Agents**: KP46 (Gallium 8-quinolinolate) and Gallium Maltolate show high bioavailability and potential against bladder cancer and lymphomas.\n\n# Group 14 and Group 15 Elements\n\n* **Group 14 (Carbon Group)**: C, Si, Ge, Sn, Pb.\n * **Silicon (Si)**: Used as bioisosteres in drug design. Sila-haloperidol and Sila-venlafaxine are silicon analogues of known antipsychotics/antidepressants with altered lipophilicity and pharmacokinetics.\n * **Organogermanium**: Ge-132 (Germanium sesquioxide) studied for anticancer and immune-modulating activity. Spirogermanium tested for ovarian cancer (clinically limited by neurotoxicity).\n* **Group 15 (Nitrogen Group)**: N, P, As, Sb, Bi.\n * **Phosphorus (P)**: Essential for DNA and ATP. Phosphate supplements used for hypophosphataemia and as enemas (clearing the bowel).\n * **Bisphosphonates**: Structural analogues of pyrophosphate; treat osteoporosis by binding to hydroxyapatite and slowing metabolic activity.\n * **Arsenic (As)**: **Salvarsan** (Compound 606) discovered by Paul Ehrlich in 1909 for syphilis; regarded as the start of chemotherapy. **Trisenox** (Arsenic trioxide) is FDA-approved for relapsed Acute Promyelocytic Leukaemia (APL).\n\n# Transition Metals (d-Block Metal Chemistry)\n\n* **Definition**: elements with an incomplete d-subshell. Exhibit characteristic colors and paramagnetism (unpaired electrons).\n* **Geometries**: Determined by Kepert model. Common: Linear (CN 2), Tetrahedral/Square Planar (CN 4), Octahedral (CN 6).\n* **Crystal Field Theory (CFT)**: Describes the splitting of d-orbital energy levels (t{2g}$and$e_g) when approached by ligands. Affects color and magnetic properties (high-spin vs. low-spin).\n* **Platinum Anticancer Agents**:\n * **Cisplatin (cis-[Pt(II)Cl_2(NH_3)_2])**: Discovered serendipitously by Rosenberg (1965). Mode of action: Hydrolysis in the cell (↓ Cl^-$) → binds to DNA at N7 of Guanine → forms$1,2 ext{-}d(GG)$intrastrand cross-links ($65\%) → DNA kinking → apoptosis.
  • Resistance: Caused by glutathione/metallothionein binding or high DNA repair (NER system).
  • Carboplatin: Second-generation; bidentate cyclobutane-1,1-dicarboxylate ligand; less toxicity (nephrotoxicity/ototoxicity) but more myelosuppression.
  • Oxaliplatin: Third-generation; contains DACH ligand; effective against colon cancer; hinders DNA repair sterically.
• Iron (Fe): Required for haemoglobin (oxygen transport), myoglobin (storage), and cytochromes (electron transfer). Functional unit is the haeme group.
  • Bleomycin (BLM): Glycopeptide antibiotic; forms ‘activated BLM complex’ ($HOO\text{--}Fe(III)BLM$) that cleaves DNA.
• Ruthenium (Ru): NAMI-A (metastatic cancer) and KP1019 (colon cancer) entered clinical trials. Mechanisms involve ‘activation by reduction’ from Ru(III) to Ru(II).
• Coinage Metals:
  • Copper (Cu): Bound to ceruloplasmin for transport. Wilson Disease: Toxic copper accumulation treated with D-penicillamine or Zinc acetate.
  • Silver (Ag): Antimicrobial. Silver nitrate pen for warts; Silver sulfadiazine cream for burn wounds.
  • Gold (Au): DMARDs for Rheumatoid Arthritis. Auranofin (oral gold) and Sodium aurothiomalate (IM injection). Metabolism involves thiol exchange with albumin.
• Zinc (Zn): Essential co-factor in over 300 enzymes (e.g., Carboanhydrase, Carboxypeptidase A). Zinc Fingers stabilize DNA-binding protein structures.

Organometallic Chemistry and Metallocenes

• Definition: Compounds containing one or more metal-carbon bonds.
• Metallocenes: Sandwich complexes of type $(\eta^5\text{-}Cp)_2M$, where the metal is between two cyclopentadienyl ligands.
• Ferrocene [(\eta^5 ext{-}C_5H_5)_2Fe]: Stable 18-electron complex. Used as biosensor mediators (electron sinks) in blood glucose monitors (handheld pen-sized devices).
  • Ferroquine: Antimalarial analogue of chloroquine active against resistant strains.
  • Ferrocifen: Tamoxifen derivative for oestrogen-independent breast cancer.
• Titanocenes: Titanocene dichloride ($Cp_2TiCl_2$) initially showed promise but failed Phase II trials due to hydrolytic instability and side effects (renal/liver damage).
• Vanadocenes: Bis(maltolato)oxovanadium (BMOV) and BEOV are potent insulin mimetics. Inhibit PTP1B (Protein Tyrosine Phosphatase 1B), increasing insulin sensitivity.

Lanthanoids and Radioactivity

• Lanthanoids (f-block): Trivalent cations ($Ln^{3+}$).
  • Lanthanum Carbonate (Fosrenol): Phosphate binder for ESRF patients; chewed with meals.
  • Gadolinium (Gd): Paramagnetic [Xe]$4f^7$ configuration. Administered as stable chelates (Magnevist, Dotarem) as MRI contrast agents.
• Radioactivity: Spontaneous energy loss by an unstable nucleus. Units: Curie (Ci) or Becquerel (Bq, $1\,\text{dps}$). Absorbed dose in Gray (Gy); dose equivalent in Sievert (Sv).
  • Types of Decay:
    • Alpha ($\alpha$): Emission of $^4_2He^{2+}$; short range; high cell damage; limited clinical use.
    • Beta minus ($\beta^-$): Neutron → proton + negatron ($\beta^-$) + antineutrino. Used for therapy ($^{131}\text{I}$, $^{89}\text{Sr}$).
    • Positron ($\beta^+$): Proton → neutron + positron ($\beta^+$) + neutrino. Used in PET imaging ($^{18}\text{F}$, $^{68}\text{Ga}$).
    • Gamma ($\gamma$): Electromagnetic radiation; high penetration; detectable by Gamma Camera.
• Half-life Calculation: $A = A_0 \cdot e^{-\lambda t}$, where $\lambda = \frac{0.693}{t_{1/2}}$.
• Medical Radioisotopes:
  • Technetium-$99m$ ($^{99m}\text{Tc}$): Generated in situ from Molybdenum-$99$; half-life $6\,h$; only emits $\gamma$-rays. Used as exametazime (brain), sestamibi (heart), medronate (bones).
  • Iodine-$131$ ($^{131}\text{I}$): Used for hyperthyroidism and metastatic thyroid cancer (accumulates in thyroid gland).
  • Fluorine-$18$ ($^{18}\text{F}$): Used as FDG (Fluorodeoxyglucose) for PET scans to assess glucose metabolism in cancers and epilepsy.
  • Boron Neutron Capture Therapy (BNCT): Injection of $^{10}\text{B}$ targetted to tumor, then exposed to thermal neutrons → reaction emits localized Alpha particles and Lithium-$7$.

Chelation Therapy

• Definition: binding of polydentate ligands to a single metal atom (‘chelating effect’ is preferred thermodynamically over monodentate ligands).
• Applications: removal of toxic heavy metals (Lead, Mercury, Arsenic) or excess essential metals (Copper in Wilson Disease).
• Chelating Agents:
  • Calcium Disodium Edetate (EDTA): Hexadentate ligand; treats lead poisoning. chromium-EDTA evaluates kidney filtration.
  • Dimercaprol (BAL): Thiol-based; developed as antidote to Lewisite; treats arsenic, gold, and mercury poisoning; painful IM injection in peanut oil.
  • Succimer (DMSA): Water-soluble modification of BAL; lower toxicity; treats lead, arsenic, and mercury.
  • Lipoic Acid (ALA): Antioxidant food supplement; can chelate mercury and cross the blood-brain barrier.

Exercise & Case Study Concepts

• Atomic Analysis: Electron configurations for ions (e.g., $Na^+, Si, Cl^-$).
• Titration: Quantitative analysis of active pharmaceutical ingredients (APIs). Example: Lithium carbonate titration with $HCl/NaOH$; Aluminum hydroxide gravimetric analysis using 8-hydroxy quinolone.
• Specific Activity: amount of radioactivity per unit mass ($\text{mCi/mg}$).
• Dose Calculations: Adjusting radiopharmaceutical quantity based on activity concentration and elapsed decay time.